These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29496413)

  • 1. Structural basis of the broad substrate tolerance of the antibody 7B9-catalyzed hydrolysis of p-nitrobenzyl esters.
    Miyamoto N; Yoshimura M; Okubo Y; Suzuki-Nagata K; Tsumuraya T; Ito N; Fujii I
    Bioorg Med Chem; 2018 May; 26(8):1412-1417. PubMed ID: 29496413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-catalyzed removal of the p-nitrobenzyl ester protecting group: the molecular basis of broad substrate specificity.
    Kurihara S; Tsumuraya T; Suzuki K; Kuroda M; Liu L; Takaoka Y; Fujii I
    Chemistry; 2000 May; 6(9):1656-62. PubMed ID: 10839182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
    Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
    J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of a catalytic antibody: an arginine and a histidine residue play key roles.
    Stewart JD; Roberts VA; Thomas NR; Getzoff ED; Benkovic SJ
    Biochemistry; 1994 Mar; 33(8):1994-2003. PubMed ID: 8117656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
    Mouratou B; Stetefeld J
    Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A catalytic antibody that accelerates the hydrolysis of carbonate esters. Prediction of the binding-site structure of the substrate.
    Suzuki H; Mukouyama EB; Wada C; Kawamura-Konishi Y; Wada Y; Ono M
    J Protein Chem; 1998 Apr; 17(3):273-8. PubMed ID: 9588951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates].
    Mokrushina YA; Pipiya SO; Stepanova AV; Shamborant OG; Knorre VD; Smirnov IV; Gabibov AG; Vorobiev II
    Mol Biol (Mosk); 2017; 51(6):958-968. PubMed ID: 29271960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse structural solutions to catalysis in a family of antibodies.
    Gigant B; Tsumuraya T; Fujii I; Knossow M
    Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of an antibody-catalyzed reaction.
    Stewart JD; Krebs JF; Siuzdak G; Berdis AJ; Smithrud DB; Benkovic SJ
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7404-9. PubMed ID: 8052597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inactivation of a catalytic antibody by p-nitrophenyl esters.
    Gigant B; Charbonnier JB; Golinelli-Pimpaneau B; Zemel RR; Eshhar Z; Green BS; Knossow M
    Eur J Biochem; 1997 Jun; 246(2):471-6. PubMed ID: 9208940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.